ArticleBioscience reports2026
Renal function dynamics in COVID-19: exploring biomarker interactions with D-dimer and C-reactive proteins.
Article in Bioscience reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
COVID-19, caused by the SARS-CoV-2 virus, is mainly recognized for its respiratory manifestations. However, growing evidence regarding the widespread expression of ACE2 and TMPRSS2 receptors on diverse extrapulmonary sites, particularly in renal tubular epithelial cells, suggests susceptibility of other organ systems, including the kidneys, to such conditions as acute kidney injury (AKI). In the present retrospective study, we explored the interrelationship between disease severity and renal function abnormalities by analyzing key biochemical parameters: blood urea nitrogen (BUN), serum creatinine (Cr), the BUN/Cr ratio, and estimated glomerular filtration rate (eGFR). Using descriptive statistics and joint generalized linear models, we examined both the mean and variance components of these markers alongside inflammatory indicators such as C-reactive protein (CRP) and D-dimer. Our findings revealed a significant positive correlation between serum urea levels and both CRP and D-dimer concentrations, suggesting that elevated urea may reflect heightened inflammatory activity. Additionally, eGFR showed a positive association with CRP, indicating potential renal involvement in systemic inflammation. Our in silico studies supported such observations, as genes responsible for CRP and D-dimer elevation were found to be common in AKI-associated pathways, particularly IL-6/JAK-STAT, NF-κB, HIF-1, and complement pathways, ultimately causing renal microthrombosis, tubular necrosis, and fibrotic remodeling. Notably, serum Cr revealed no significant association with CRP or D-dimer, possibly due to its lower sensitivity in early renal dysfunction. Although the study is limited by a relatively small sample size and lacks longitudinal data, it underscores the importance of monitoring renal function parameters in COVID-19 patients as potential markers of disease progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.